John is a general partner at Kindred Capital and a board member at Fractile and Latent Labs. He previously served as general manager for genomics at Dante Labs and founded CCG.ai.
The financing round was co-led by Radical Ventures and Sofinnova Partners to accelerate the development of programmable biology tools.
"Every biotechnology or pharmaceutical company wants to be at the forefront of technology to find the best therapeutic molecules, yet not all are in a position to develop the most advanced AI models for the job. That’s where Latent Labs comes in. We push the frontiers of generative biology, giving our partners instant access to tools that accelerate their drug design programs."
The seed round was co-led by Kindred Capital, NATO Innovation Fund, and Oxford Science Enterprises.
"In today’s AI race, the limitations of existing hardware – nearly all of which is provided by a single company – represent the biggest barrier to better performance, reduced cost, and wider adoption. Fractile’s approach supercharges inference, delivering astonishing improvements in terms of speed and cost. This is more than just a speed-up – changing the performance point for inference allows us to explore completely new ways to use today’s leading AI models to solve the world’s most complex problems. We’re thrilled to have raised our funding from investors with a wealth of experience in the AI and chip industries, continue to grow our world-class team and further our technological development and partnerships."
Atomico led the Series A round with participation from existing investors including Lakestar, Kindred, and Maersk Growth.
"For those operating warehouses, ensuring 100% fulfilment ‘in time, all the time’ is crucial to meeting the demands of the modern consumer. A critical component to achieving this is high stock accuracy, but staff shortages, manual processes, and the speed demanded by customers means that critical decisions across the supply chain are currently being taken blindly,"